Our group demonstrated that TFF1 correlates with a higher clinical tumor-node-metastasis (TNM) stage and poorly differentiated tumor cells [8] and a recent study showed that TFF1 is linked to RBs which are associated with a higher risk of metastasis, referred to as subtype 2 [4]. Here, TFF1 is linked to neoplasm.